Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
NCT06569316
Summary
This clinical trial is studying the genetic changes in cells associated with different types of cancer in Indigenous American (IA) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. IA tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, IAs have been understudied and little is known about the molecular characterization of tumors arising in IAs. Undergoing genetic testing of tumors may improve cancer outcomes in IA participants and communities.
Eligibility
Inclusion Criteria: * Male or female adults \>= 18 years of age * Cancer patient undergoing active treatment or a cancer survivor * Self-identify as Indigenous American Exclusion Criteria: * Unable to provide informed consent * Individuals who are under 18 years of age * Prisoners
Conditions3
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06569316